Concepedia

Multicenter phase II study of oral capecitabine (Xeloda“) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy

Peter Reichardt, Gϋnter von Minckwitz, Peter Thuss‐Patience, W. Jonat, H Kölbl, F. Jänicke, D G Kieback, W. Kühn, A. E. Schindler, Svjetlana Mohrmann,

Annals of Oncology · 2003 · 237 citations · 18 references

Open access

Concepts

MedicineOncologyPharmacologyBreast OncologyCancer PharmacologyChemotherapyBreast Cancer PharmacotherapyMalignant NeoplasmsMetastatic Breast CancerMetastatic Cancer ManagementMetastatic Disease TreatmentSystemic Therapy For Breast CancerBreast Cancer ChemotherapyCapecitabine-based TherapyMetastatic Breast Cancer TreatmentTaxane TherapyTaxane-based Chemotherapy

References

18

Reporting results of cancer treatment

A. B. Miller, Barth Hoogstraten, M. Staquet et al. · Cancer · 1981 · 7.9K citations

Pharmacy, Oncology, Clinical Data Management +16

WHO Handbook for Reporting Results of Cancer Treatment

M K Palmer · British Journal of Cancer · 1982 · 2.2K citations · Full text

Medicine, Oncology, Cancer Control +11

Cancer statistics, 1996

T. Tong, S. Bolden, Phyllis A. Wingo · CA A Cancer Journal for Clinicians · 1996 · 1.8K citations · Full text

Medicine, Biostatistics, Oncology +17

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

Masanori Miwa, Masako Ura, M Nishida et al. · European Journal of Cancer · 1998 · 1.2K citations

Medicine, Oncology, Pharmacology +12

Superior Survival With Capecitabine Plus Docetaxel Combination Therapy in Anthracycline-Pretreated Patients With Advanced Breast Cancer: Phase III Trial Results

Joyce O’Shaughnessy, David Miles, Svetislava J. Vukelja et al. · Journal of Clinical Oncology · 2002 · 1.1K citations

Medicine, Oncology, Pharmacology +14